Related Experiment Video
Updated: Jan 16, 2026

Systematic Approach to Identify Novel Antimicrobial and Antibiofilm Molecules from Plants' Extracts and Fractions to Prevent Dental Caries
Published on: March 31, 2021
Murraya koenigii methanolic extract inhibits bacterial growth and biofilm of Staphylococcus aureus and Enterococcus
Shashank Kashyap1, Yashkumar Rathod1, Sumit Biswas2
1ViStA lab, Department of Biological Sciences, BITS-Pilani, KK Birla Goa Campus, Goa, 403726, India.
Abstract:
Hospital-acquired infections caused by Staphylococcus aureus and Enterococcus faecalis are significant global health challenges due to their biofilm-forming ability, also contributing to the derived antibiotic resistance and environmental persistence. This growing resistance poses serious global health challenges, emphasizing the need for better surveillance and new treatments. Plant-derived bioactives have emerged as possible therapeutics to such opportunistic pathogens and they are potential alternatives to traditional antimicrobials. This study investigates the in vitro activity of Murraya koenigii's methanolic (MKM) leaf extract and its compounds against the growth and biofilm-forming ability of S. aureus and E. faecalis. Results revealed that the MKM extract effectively inhibited the growth of S. aureus and E. faecalis at their respective MIC levels. Furthermore, flow cytometry and confocal imaging demonstrated substantial membrane damage in MKM-treated cells compared to DMSO-treated and untreated controls. Additionally, the MKM extract significantly disrupts biofilm formation and leads to reduced extracellular polymeric substance (EPS) production. Scanning electron microscopy provided visual evidence of disrupted biofilm architecture following MKM extract treatment. HR-LC/MS analysis identified bioactive compounds within the extract, which were further evaluated for drug-likeness properties through ADME analysis. In silico molecular docking studies confirmed strong binding affinities of MKM-derived compounds with key biofilm-related receptor proteins, SpA in S. aureus and Esp in E. faecalis. These findings highlight the significant potential of MKM extract as a novel and effective phytotherapeutic resource for developing strategies to combat biofilm-associated infections.
Insights
Murraya koenigii leaf extract effectively combats Staphylococcus aureus and Enterococcus faecalis infections by inhibiting growth and disrupting biofilms. This plant-derived compound shows promise as a novel phytotherapeutic agent against antibiotic-resistant bacteria.
Area of Science:
- Microbiology
- Pharmacology
- Natural Products Chemistry
Background:
- Hospital-acquired infections caused by Staphylococcus aureus and Enterococcus faecalis are major global health concerns.
- These pathogens' ability to form biofilms contributes to antibiotic resistance and environmental persistence.
- There is an urgent need for novel therapeutic strategies to combat these resilient infections.
Purpose of the Study:
- To investigate the in vitro efficacy of Murraya koenigii methanolic leaf extract (MKM) against Staphylococcus aureus and Enterococcus faecalis.
- To evaluate the extract's impact on bacterial growth, biofilm formation, and membrane integrity.
- To identify bioactive compounds in MKM and assess their potential therapeutic applications through in silico analyses.
Main Methods:
- In vitro antimicrobial activity testing, including Minimum Inhibitory Concentration (MIC) determination.
- Flow cytometry and confocal imaging to assess membrane damage.
- Scanning electron microscopy (SEM) for biofilm architecture visualization.
- High-Resolution Liquid Chromatography-Mass Spectrometry (HR-LC/MS) for compound identification and ADME analysis.
- In silico molecular docking studies against bacterial biofilm-related proteins.
Main Results:
- MKM extract demonstrated significant inhibition of both S. aureus and E. faecalis growth at their respective MICs.
- The extract caused substantial membrane damage in treated bacterial cells.
- MKM extract effectively disrupted biofilm formation and reduced extracellular polymeric substance (EPS) production.
- SEM confirmed the disruption of biofilm architecture.
- In silico analyses revealed strong binding affinities of identified compounds with key biofilm proteins (SpA and Esp).
Conclusions:
- Murraya koenigii methanolic leaf extract possesses significant antimicrobial and anti-biofilm properties against S. aureus and E. faecalis.
- The extract's mechanism involves membrane damage and disruption of biofilm matrix.
- Identified bioactive compounds show potential for developing new phytotherapeutic strategies against biofilm-associated infections.
- MKM extract represents a promising natural resource for combating antibiotic-resistant pathogens.
Related Concept Videos
Biological Methods for Microbial Control
Antimicrobial Effectiveness
Surface Membrane Barriers
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
Biofilms
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...

